In the latest sign that intellectual property litigators continue to be in high demand this year, King & Spalding has picked up a pair of partners from Paul Hastings who represent brand-name pharmaceutical companies in patent cases.

The Atlanta-founded Am Law 100 firm announced Monday that it had hired Gerald Flattmann and Evan Diamond as partners for its trial and disputes practice group in New York. Flattmann, who spent the last eight years at Paul Hastings, arrived at that firm from Kirkland & Ellis in 2010. He will now serve as chairman of the King & Spalding’s life sciences patent litigation practice.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]